Trajectory of Psychological Distress Among Infertility Women

Sponsor
Taipei Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04829877
Collaborator
(none)
750
1
3
7.4
101

Study Details

Study Description

Brief Summary

Background: Infertility is a serious reproductive health issue and affects 48.5 million couples worldwide. Women undergoing fertility treatment often experienced psychological distress but also social stigma that is close linked to later pregnancy outcome. Despite the advancement in assisted reproductive technology, effective interventions for reducing stress, anxiety, and depressive symptoms for infertility women remain lacking.

Objectives: The objective of this proposal is to evaluate the efficacy of web-based mind-body intervention combining HRV biofeedback on the infertility women's anxiety symptoms, levels of depression, HRV function, mindful awareness, infertility self-efficacy, and pregnancy rates.

Methods: We plan to conduct a randomized controlled trial on the web-based mind-body intervention combining heart rate variability biofeedback. Eligible women will be recruited and randomized into three groups. Intention-to-treat analysis and mixed regression modeling will be used to estimate the effectiveness of the interventions.

Anticipatory results: Effective strategies will be determined for infertility women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Web-based mind-body intervention with HRVB
  • Behavioral: Web-based mind-body intervention
N/A

Detailed Description

A designed data entry system for the current study will be developed to ensure an error-proof process. It is important to inspect data for outliers, wild code, and consistency to maintain the data quality in the pre-analysis data phase. We will assess the amount and pattern of missing values by using descriptive statistics, such as frequency and percentage. The pattern of missing data will be identified and decide whether the missing completely at random or not. The appropriate corresponding method will be adopted for the subsequent statistical analyses. For example, the mean imputation is considered when the percentage of items missing at a given questionnaire is less than 10 %. The mean imputation will be used to replaces a missing value with the item mean when applicable. The comparison between complete case analysis and imputation data will be performed to assess the reliability and validity of the results.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
750 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Trajectory of Psychological Distress Among Infertility Women: Efficacy and Mechanism of Mind-body Intervention With Heart Rate Variability Biofeedback
Actual Study Start Date :
Apr 19, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Web-based mind-body intervention with HRVB

Both standard usual care and the web-based mind-body intervention with HRV biofeedback (MBI-HRVB) will be provided to the participants. The web-based mind-body intervention with HRV biofeedback program consisted of 5-week training sessions and breathing training.

Behavioral: Web-based mind-body intervention with HRVB
The web-based mind-body intervention with HRVB contains the following components: 1) Breathing training with HRV biofeedback; 2) 5 different topics will be included ; 3) Home exercise of slow breathing and mindfulness exercise.

Experimental: Web-based mind-body intervention

Both standard usual care and the web-based mind-body intervention will be provided to the participants. The web-based mind-body intervention program consisted of 5-week training sessions.

Behavioral: Web-based mind-body intervention
The web-based mind-body intervention will receive 5 different topics courses.

No Intervention: Control

The women in the control group will receive the standard usual care provided at the fertility clinic. The standard care protocols encompass elements such as routine assessment and health education at each visit. Participants enrolled in the control group will be approached once a week by a nurse to provide health consultation about fertility treatment, medication, signs, and symptoms of discomfort for five weeks.

Outcome Measures

Primary Outcome Measures

  1. Anxiety [Baseline]

    Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).

  2. Anxiety [1 week post-intervention]

    Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).

  3. Anxiety [1 month post-intervention]

    Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).

  4. Anxiety [2 month post-intervention]

    Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).

  5. Anxiety [3 month post-intervention]

    Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI).

Secondary Outcome Measures

  1. Depressive symptoms [Baseline, post-intervention 1 week, month 1 , 2 and 3]

    The Taiwanese version of the Beck Depression Inventory (BDI) will be used to assess depressive symptoms among infertility women.

  2. HRV function [Baseline, post-intervention 1 week, month 1 , 2 and 3]

    The HRV signal will be measured using standard equipment.

  3. Mindful awareness [Baseline, post-intervention 1 week, month 1 , 2 and 3]

    The Taiwanese version of the Five Facet Mindfulness Questionnaire (FFMQ) will be adopted to assess levels of mindfulness.

  4. Infertility self-efficacy [Baseline, post-intervention 1 week, month 1 , 2 and 3]

    The infertility Self-Efficacy Scale (ISE) will be used for studied women.

  5. Pregnancy rates [15 days after embryo transfer or ultrasound]

    Clinical pregnancy will be defined as a positive blood, urinary pregnancy test.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 20-year-old and above

  • Seeking infertility care

  • Contemplating pregnancy

  • Intended to start their ART cycle

  • Able to speak Taiwanese or Mandarin

Exclusion Criteria:
  • Diagnosis of cardiovascular disease, depressive disorder, anxiety disorder, cardiac arrhythmia

  • Already had started their ART treatment

  • Taking medications that might affect ANS activity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Infertility clinic Taipei Taiwan 110

Sponsors and Collaborators

  • Taipei Medical University

Investigators

  • Principal Investigator: Shu-Yu Kuo, Phd, Taipei Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shu Yu Kuo, Principal investigator, Taipei Medical University
ClinicalTrials.gov Identifier:
NCT04829877
Other Study ID Numbers:
  • N201807030
First Posted:
Apr 2, 2021
Last Update Posted:
Jun 15, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shu Yu Kuo, Principal investigator, Taipei Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2022